JPS6213327B2 - - Google Patents
Info
- Publication number
- JPS6213327B2 JPS6213327B2 JP51119064A JP11906476A JPS6213327B2 JP S6213327 B2 JPS6213327 B2 JP S6213327B2 JP 51119064 A JP51119064 A JP 51119064A JP 11906476 A JP11906476 A JP 11906476A JP S6213327 B2 JPS6213327 B2 JP S6213327B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- antitumor
- mice
- drug
- yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 8
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 8
- 239000002246 antineoplastic agent Substances 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- 229920000057 Mannan Polymers 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 229920001503 Glucan Polymers 0.000 claims description 4
- 229920002527 Glycogen Polymers 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 229940096919 glycogen Drugs 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 241000699670 Mus sp. Species 0.000 description 12
- 206010028980 Neoplasm Diseases 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 230000000259 anti-tumor effect Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 6
- 206010003445 Ascites Diseases 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003447 ipsilateral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 229920000392 Zymosan Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11906476A JPS5344614A (en) | 1976-10-04 | 1976-10-04 | Antitumor agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11906476A JPS5344614A (en) | 1976-10-04 | 1976-10-04 | Antitumor agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5344614A JPS5344614A (en) | 1978-04-21 |
JPS6213327B2 true JPS6213327B2 (enrdf_load_stackoverflow) | 1987-03-25 |
Family
ID=14751996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11906476A Granted JPS5344614A (en) | 1976-10-04 | 1976-10-04 | Antitumor agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5344614A (enrdf_load_stackoverflow) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4313934A (en) * | 1979-05-08 | 1982-02-02 | Kirin Beer Kabushiki Kaisha | Physiologically active polysaccharides, production and uses thereof |
JP2583183B2 (ja) * | 1993-02-12 | 1997-02-19 | 青森県 | 生理活性を有するグリコーゲンの製法及び生理活性 |
AUPN398295A0 (en) | 1995-07-05 | 1995-07-27 | Carlton And United Breweries Limited | Chemical compounds and processes for their production |
IT1298758B1 (it) * | 1998-03-19 | 2000-02-02 | Angelini Ricerche Spa | Soluzione umettante e lubrificante per uso oftalmico |
-
1976
- 1976-10-04 JP JP11906476A patent/JPS5344614A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5344614A (en) | 1978-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0295956B1 (en) | Use of a protein-bound polysaccharide for making a drug for treating AIDS. | |
SU730277A3 (ru) | Способ получени азотсодержащих полисахаридов, обладающих противоопухолевым действием | |
DE2655844B2 (de) | Verfahren zur Herstellung antitumorwirksamer Substanzen | |
DE3017372A1 (de) | Physiologisch aktive polysaccharide, verfahren zu ihrer herstellung sowie ihre verwendung | |
SU704431A3 (ru) | Способ получени полисахаридов, обладающих противоопухолевым действием | |
RU2308460C2 (ru) | Полисахарид из корней echinacea angustifolia, способ его получения, фармацевтическая композиция | |
DE2919132A1 (de) | Substanz ks-2-b, verfahren zu deren herstellung und diese substanz enthaltende mittel | |
JPH0539305A (ja) | アストラガルス・メンブラナセウスから抽出した免疫 変調性多糖類及びこれらを含有する薬剤組成物 | |
JPS6213327B2 (enrdf_load_stackoverflow) | ||
US4851395A (en) | Nitrogen-containing polysaccharide | |
US4335239A (en) | Polyribonucleotides capable of promoting the genesis of leucocytes and blood platelets | |
JPH05117303A (ja) | ヤマブシタケ由来の水溶性多糖類及び該水溶性多糖類を主剤とする抗腫瘍剤 | |
US6015796A (en) | Method for treating AIDS | |
DE2614393C3 (de) | Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel | |
KR101790654B1 (ko) | 잣박 추출물과 이를 유효성분으로 포함하는 간암의 예방 또는 치료용 조성물 | |
JP2007031665A (ja) | マイタケから抽出した糖―タンパク複合体 | |
JP3129751B2 (ja) | ブナシメジ子実体熱水抽出物 | |
JP4480204B2 (ja) | カワリハラタケの抗腫瘍性画分 | |
JP2008214246A (ja) | Age生成阻害剤およびその製造方法 | |
JP3072321B2 (ja) | 抗hiv活性物質およびその製造方法 | |
JPH0245501A (ja) | 竹節ニンジン多糖およびその用途 | |
JPH0434527B2 (enrdf_load_stackoverflow) | ||
JPH09286734A (ja) | グリセロリン酸脱水素酵素阻害剤 | |
GB1581315A (en) | Polysaccharides and process for the preparation thereof | |
JPH05117304A (ja) | ヤマブシタケ由来の水不溶性多糖類及び該水不溶性多糖類を主剤とする抗腫瘍剤 |